Trans American Aquaculture (GRPS) EBIT Margin (2023 - 2024)
Trans American Aquaculture (GRPS) reported EBIT Margin of 1193.12% for Q4 2024, down 76728.0% on a YoY basis from N/an in Q1 2024, and up 51.61% quarter-over-quarter from 2465.53% in Q2 2024.
Trans American Aquaculture (GRPS) EBIT Margin (2023 - 2024) Analysis & Trends
Trans American Aquaculture has reported EBIT Margin for 2 years, with the latest figure at 1193.12% in Q4 2024.
- For the quarter ending Q4 2024, EBIT Margin fell 76728.0% year-over-year to 1193.12%; the trailing twelve-month figure through Sep 2025 stood at 2807.41% (down 254329.0% YoY), and the FY2024 full-year result was 252.14%, up 115057.0% from the prior year.
- EBIT Margin for Q4 2024 stood at 1193.12%, up from 2465.53% in the prior quarter.
- The five-year high for EBIT Margin was 43.37% in Q1 2024, with the low at 2465.53% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 16.37% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 36.83% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 41.69% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 20.77% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 23.74% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 22.39% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -122.23% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -12.88% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 21.55% |
| 10 | Trans American Aquaculture | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -1,193.12% |
| Jun 30, 2024 | -2,465.53% |
| Mar 31, 2024 | -43.37% |
| Dec 31, 2023 | -425.84% |